
Hepcludex FDA Approval: First Treatment for Hepatitis D
Review the FDA accelerated approval of Hepcludex (bulevirtide) for chronic hepatitis delta virus (HDV), including clinical trial data and public health impact.

Review the FDA accelerated approval of Hepcludex (bulevirtide) for chronic hepatitis delta virus (HDV), including clinical trial data and public health impact.
© 2026 IntuitionLabs. All rights reserved.